NASPGHAN 2026
The Division of Gastroenterology, Hepatology & Nutrition at Children’s Hospital of Philadelphia (CHOP) is pleased to join the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) at its 2026 Annual Meeting Oct. 21-24, at the Marriott Marquis San Diego Marina in San Diego, CA.
CHOP is the nation’s first hospital devoted exclusively to the care of children. Since our start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. CHOP – and its GI Division – have repeatedly earned a spot on the U.S. News & World Report’s Honor Roll of the nation’s best children’s hospitals.
Leading CHOP’s Division of Gastroenterology, Hepatology and Nutrition is Division Chief Binita M. Kamath, MBBChir, MRCP, MTR, an internationally known GI leader and world-renowned pediatric hepatology expert who has a special focus on liver disorders in children.
Dr. Kamath and many other GI physicians (including those listed below) will represent CHOP at NASPGHAN as session speakers, poster presenters and exhibitors:
- Christina B. Bales, MD, Medical Director of the Intestinal Rehabilitation Program
- Andrew B. Grossman, MD, Co-Director of the Center for Pediatric Inflammatory Bowel Disease
- Judith R. Kelsen, MD, Program Director of the Very Early Onset Inflammatory Bowel Disease (VEO-IBD)
- Petar Mamula, MD, Director of the Kohl’s GI Nutrition and Diagnostic Center at CHOP
- Michael A. Manfredi, MD, Co-Director of the Esophageal and Airway Treatment Program
- Hayat Mousa, MD, Director of the Suzi and Scott Lustgarten Center for GI Motility Center
- Amanda Muir, MD, MTR, Co-Director of the Gastrointestinal Epithelium Modeling Program
This page will give you all the details you need to know about CHOP at NASPGHAN as well as how you can stay connected with CHOP and access CHOP’s many professional resources.
Join us for an evening reception at NASPGHAN
Please join CHOP for an evening reception on Friday, Oct. 23, as we bring some Philly flair to “America’s Finest City.” Enjoy beer, wine and hors d’oeuvres in an informal setting overlooking the San Diego Bay during NASPGHAN’s annual meeting. Connect with Dr. Kamath and other former and current colleagues.
CHOP live presentations at NASPGHAN
Wednesday, Oct. 21: NASPGHAN Single Topic Symposium
Pediatric Intestinal Failure in the Modern Era: Advancing knowledge, therapeutic innovations, and shaping the future through building collaborative workforce
11:30 a.m. – 12:30 p.m.: Lunch Sessions
Oct 21: Option D:
“Stump the international experts: The neonate with ultrashort bowel syndrome”
Moderator: Christina B. Bales, MD; Co-presenter: Nikhil Pai, MD
Advancing Pediatric Endoscopy: Bridging Gaps in Therapeutic Skills for Everyday Practice
- Course director/Event moderator: Michael A. Manfredi, MD
8:10 – 8:50 p.m.: Keynote
“Endoscopy Training: Past, Present and Future”
Hands-on Stations – Faculty List
Thursday, Oct. 22: Postgraduate Course
8 – 9:20 a.m.: Module 1: Inflammatory Diseases
Moderator: Lindsay G. Albenberg, DO
Thursday, Oct. 22: NASPGHAN Annual Meeting
4 – 5 p.m.: Fifth Annual NASPGHAN Baby Shark Tank Competition
5 – 7 p.m.: Reception in the Exhibit Hall (Exhibit Hall opens) & Poster Session I (A list of posters by CHOP staff is below)
Friday, Oct. 23: NASPGHAN Annual Meeting
7 – 8 a.m.: Inaugural Fireside Chat & Meet the Professor Breakfasts
10 a.m. – 2 p.m.: Exhibit Hall open
10:30 a.m.-noon: Concurrent Session I
“Mind the Gut”
Decoding feeding intolerance in DGBI: Practical approach, by Hayat Mousa, MD
Noon – 2:30 p.m.: Poster Session II (A list of posters by CHOP staff is below)
2:30 – 4 p.m.: Concurrent Session II
4:15 – 6 p.m. Awards Ceremony
Saturday, Oct. 24: NASPGHAN Annual Meeting
7 – 8 a.m.: Meet the Professor Breakfasts
8:30 – 10 a.m.: Concurrent Session III
“The Liver-Gut Immune Axis in Inflammatory Disease”
9:32 a.m.: Idiopathic severe hepatitis: Steroids yay or nay? by Tamir Diamond, MD
“Personalized Pediatric GI Care: What Genomics and Organoids Can Deliver Today – and Tomorrow.”
Moderator: Judith R. Kelsen, MD
“Small Patients, Big Decisions: Surgical Care in Pediatric IBD”
8:30 a.m.: To cut or to control? Managing isolate TI disease (debate), by Andrew B. Grossman, MD
10 a.m. – 2:30 p.m.: Exhibit Hall open
10:30 a.m. – noon: Concurrent Session IV
“When Wheels Wobble: Navigating Conflict, Setbacks and Career Recovery in Medicine”
10:30 a.m.: When the professional isn’t professional: Dealing with a difficult colleague, by Binita M. Kamath, MBBChir, MRCP, MTR
“Esophageal Enigmas: The Diagnostic and Treatment Conundrums of Barrett’s Esophagus and Achalasia”
10:30 a.m.: Emerging therapies in pediatric achalasia: POEM, when do you need it and how does it compare? by Michael A. Manfredi, MD
Noon – 2 p.m.: Lunch in Exhibit Hall & Poster Session III (A list of posters by CHOP staff is below)
3:45 – 5:15 p.m.: Concurrent Session IV
“Scrolls, Selectivity and Special Diets: Pediatric Feeding in the Real World”
Diagnostic and treatment considerations at the intersection of PFD/ARFIC, by Colleen Lukens, PhD
“Innovations in Pediatric Liver Disease”
Glucagon-like-peptide-1 receptor agonists (GLP1-RAS) in the treatment of pediatric metabolic dysfunction-associated steatotic liver disease, by Andrea M. Tou, MBBCh
5:30 – 6:30 p.m.: GI Jeopardy
7 – 10 p.m.: NASPGHAN Social (*separately ticketed event)
Meet our experts
Participants can meet with select CHOP experts at Booth 204-206 in the Exhibit Hall during exhibit hours.
Friday, Oct. 23
- 10 – 11 a.m.: Elizabeth “Betsy” Clabby Maxwell, MD, MS, pediatric gastroenterologist and general lead of specialized gastroenterology, hepatology and nutrition fellowships, will discuss CHOP’s six specialized GI-related fellowships
- 11 a.m. – noon: Judith R. Kelsen, MD, Program Director of the Very Early Onset Inflammatory Bowel Disease (VEO-IBD), will discuss diagnosis, treatment and research for patients with VEO-IBD
- 11 a.m. – noon: Asim Maqbool, MD, Director of CHOP’s Pancreatic Disorders Program, will discuss disorders of the pancreas, cystic fibrosis, nutrition concerns and general GI topics
- Noon – 1 p.m.: Jefferson “Naylor” Brownell, MD, MS, Co-Director of CHOP’s Pancreatic Disorders Program, will discuss lymphatics and pancreatic disorders
Saturday, Oct. 24
- 11 a.m. – noon: Andrew B. Grossman, MD, Co-Director of the Center for Pediatric Inflammatory Bowel Disease, will discuss care of pediatric patients with IBD
- Noon – 1 p.m.: Maire Abraham Conrad, MD, MS, Pediatric Gastroenterologist with expertise in inflammatory bowel disease, will discuss very early onset IBD
CHOP poster presentations at NASPGHAN
Poster Session and Networking Reception: 5-6 p.m. Wednesday, Oct. 21
Location: Exhibit Hall
204. Pull-through surgery partially restores Hirschsprung disease metagenome towards a healthy phenotype.
296. Spatial transcriptomic analysis of Hirschsprung disease: Understanding the molecular basis of Hirschsprung-associated enterocolitis.
822. Whole genome methylation profiling of patient-derived enteroids uncovers a cell-intrinsic epigenetic landscape in celiac disease with implications for epithelial regeneration.
950. Urinary metabolites reveal signature of small intestinal bacterial overgrowth (SIBO) in pediatric short bowel syndrome (SBS).
953. Hirschsprung disease organoids have a reversible colonic epithelial stem cell defect.
Poster Session I: 5-7 p.m. Thursday, Oct. 22
Location: Exhibit Hall
3. Does nutritional and socioeconomic status impact surgical wound healing for bladder exstrophy surgery: A cross-sectional analysis.
19. Rapunzel’s pancreatitis – endoscopic removal of a trichobezoar causing pancreatitis.
29. A case of gastrointestinal bleeding as a presenting symptom of a rare lymphoma.
44. Point of care unsedated transnasal endoscopy in an outpatient office setting.
45. IR-assisted rendezvous ERCP in pediatric patients: A retrospective single-center experience.
46. A case of infantile-onset juvenile polyposis syndrome treated with sirolimus following extensive polypectomy.
48. Single institution experience with unsedated, ultra-slim single-use endoscopy at a large pediatric center.
61. A single-center experience with budesonide oral solution at once-daily dosing for pediatric eosinophilic esophagitis.
97. The accuracy of blood-based biomarkers in detecting pediatric metabolic dysfunction-associated steatotic liver disease: A systemic review and meta-analysis.
119. Veno-occlusive disease after chimeric antigen receptor T-cell therapy.
147. Durability of infliximab in very early onset-inflammatory bowel disease.
156. IGA vasculitis and Crohn’s disease.
181. PLVAP-related disorder as a rare cause of neonatal protein-losing enteropathy.
204. Pull-through surgery partially restores Hirschsprung disease metagenome towards a healthy phenotype.
223. Colonic myoelectric activity associations with gastrointestinal symptoms in patients with irritable bowel syndrome.
229. The impact of meal volume on body surface gastric mapping metrics in adolescent healthy controls.
232. The role of a second dose of bisacodyl in colonic manometry.
234. Pediatric healthcare providers’ perceptions of inflammatory bowel disease and irritable bowel syndrome: A cross-sectional survey study.
259. Correlation of body surface gastric mapping with antroduodenal manometry for detection of post-prokinetic antral activity.
260. Evaluating the optimal post-prandial recording duration for body surface gastric mapping in adolescents.
267. The anatomy of early feeding transitions: High-resolution characterization of breastfeeding, supplementation and mixed feeding during the first month of life.
274. Persistent oral feeding difficulties are an early marker of growth and neurodevelopmental risk in children born extremely preterm.
283. Evaluation of utilization patterns, diagnostic yield and clinical impact of endoscopic pancreatic function testing (EPFT) in a tertiary pediatric pancreas center.
296. Spatial transcriptomic analysis of Hirschsprung disease: Understanding the molecular basis of Hirschsprung-associated enterocolitis.
302. From endoscopies to placebos: Parental perspectives on pediatric celiac trials.
Poster Session II: Noon-2:30 p.m., Friday, Oct. 23
Location: Exhibit Hall
327. Barriers and facilitator to pediatric MASLD care for Spanish-speaking Latino families.
386. Food re-introduction among children with eosinophilic esophagitis on dupilumab: Post-hoc analysis of EoE kids study at 100-weeks.
419. Pruritic improvements with odevixibat are correlated with reductions in serum bile acids and autotaxin in patients with bile sale export pump deficiency.
420. Reduction in serum bile acids with odevixibat are positively correlated with liver parameters in patients with bile salt export pump deficiency.
457. Rapid infliximab infusions for IBD patients, a quality improvement effort at a pediatric infusion center.
459. Early ileocecal resection is common in pediatric Crohn’s disease: Clinical characteristics and predictors in a large single-center cohort.
515. Antibiotics affect the oral microbial community structure in children with inflammatory bowel disease.
524. Characterizing mucosal differences in pediatric collagenous gastritis.
542. Body surface colonic mapping identifies meal and bisacodyl-evoked colonic motility in children with chronic constipation: A feasibility study.
543. Gastrointestinal symptoms and psychosocial burden significantly impact quality of life in children with irritable bowel syndrome: A single-center experience.
549. High burden of constipation among autistic youth – a nationwide query powered by PCORNET®.
595. Five-year outcomes of a pediatric psychogastroenterology training program.
Posters during Concurrent Session II: 2:30 – 4 p.m., Friday, Oct. 23
612. A four-week web-based mind-gut video intervention reduces somatic stress and anxiety in children with functional abdominal pain.
615. Dietary fiber reduces C. difficile carriage and virulence in an asymptomatic carriage model.
Flash abstracts during Concurrent Session V: 2-3:30 p.m., Saturday, Oct. 24
950. Urinary metabolites reveal signature of small intestinal bacterial overgrowth (SIBO) in pediatric short bowel syndrome (SBS).
952. Risk stratification of celiac disease using high-resolution HLA-DQ genotyping in a pediatric population.
Poster Session III: Noon-2 p.m., Saturday, Oct. 24
Location: Exhibit Hall
682. Exploring the association between fecal calprotectin level and polyp burden in patients with juvenile polyposis syndrome.
684. Crossing the chasm – managing a grade IV pancreatic injury with ERCP.
738. A “maximum echogenicity.”
747 & 748. Early experience with resmetirom in adolescents with metabolic dysfunction-associated steatohepatitis: A case series.
792. Comparative effectiveness of intensified versus standard infliximab dosing for pediatric Crohn’s disease.
793. Neurocognitive outcomes in children with inflammatory bowel disease.
794. Pediatric perianal Crohn’s disease and surgical outcomes: A single-center experience.
822. Whole genome methylation profiling of patient-derived enteroids uncovers a cell-intrinsic epigenetic landscape in celiac disease with implications for epithelial regeneration.
823. Pain before purpura: Case series with delayed cutaneous manifestations of IGA vasculitis.
834. Screen it like you mean it: Early detection and management of diabetes risk in celiac disease.
840. Recurrent rectal prolapse associated with chronic positive-pressure ventilation in an infant born extremely preterm.
866. Trends in gastroparesis admissions and length of stay across age groups: A PHIS study.
867. Determinants of length of stay in pediatric gastroparesis: A PHIS study.
901. Zinc deficiency presenting as recurrent oral ulcerations in a 2-year-old with GJ-tube dependence.
903. Impact of multidisciplinary care on longitudinal ALT outcomes in children with MASLD.
907. Improving pediatric malnutrition care: Feasibility and barriers to implementing the P-INPAC pathway.
918. Management strategies and clinical outcomes in pediatric pancreatic trauma: A single-center experience.
923. Caregiver stress in parents of young children with very early onset-inflammatory bowel disease (VEO-IBD).
930. Psychosocial screening among youth with pancreatic disorders: Anxiety, depression and functional impairment.
Posters during Concurrent Session V: 3:45 – 5:45 p.m., Saturday, Oct. 24
950. Urinary metabolites reveal signature of small intestinal bacterial overgrowth (SIBO) in pediatric short bowel syndrome (SBS).
952. Risk stratification of celiac disease using high-resolution HLA-DQ genotyping in a pediatric population.
953. Hirschsprung disease organoids have a reversible colonic epithelial stem cell defect.
Posters during Concurrent Session VI: 3:45-5:15 p.m., Saturday, Oct. 24
961. Efficacy and safety of intrapyloric botulinum toxin injection in pediatrics: A 10-year single-center experience.
967. EUS cyst-enterostomy for infected lymphatic cyst.
Referral Information
Referring a patient outside your care is an act of trust. You must be confident that the team you refer to has the knowledge, training and experience to make a significant difference in the outcome for your patient. We are here to help you provide the best care for your patients. To discuss a potential referral, schedule or seek a second opinion, please call 215-590-3630, option #2 or email CHOPRefGI@chop.edu.
Learn what information you'll need to provide when referring a patient.
Subscribe to our professional newsletter
Sign up to receive updates on research and educational opportunities, resources for your patients, news about our clinical programs, and more.
Save the Date: Friday, Sept. 10, 2027
The 10th annual Personalized IBD and VEO-IBD Symposium: Genomics, Microbiome, Biologics and Beyond is planned for Sept. 10, 2027. The one-day virtual course will be led by GI experts from CHOP and present the latest updates in diagnosis and treatment.
- CHOP OPEN: Access CHOP’s Online Pediatric Education Network, our library of educational lectures that cover a variety of clinical topics.
- The Clinical Pathways Program incorporates evidence, best practices and expert consensus into shared models for use by clinical teams at the point of care. Topics include newly updated sessions on G, GJ or J-tube complications, malnutrition/failure to thrive in infants, constipation, appendicitis, upper GI bleeds, pre- and post-op care for patients with congenital diaphragmatic hernia, and ileocolic intussusception.
- Continuing Education, including live courses and online CEs (search by specialty).
- Pediatric Gastroenterology Fellowship programs, including specialized programs on IBD, GI motility, nutrition, hepatology and aerodigestive medicine.
- See our upcoming GI, Hepatology and Nutrition events.
Online Remote Medical Consultation Program
CHOP specialists offer in-person second opinions at CHOP to any patient and in select clinical areas offer remote consultations for patient families who live in certain states throughout the country.
Pediatric care for international families
When a family seeks the best medical care for their child, they may look beyond their home country. CHOP has welcomed thousands of international patients for care in nearly every pediatric specialty through our Global Patient Services team.